HIV Scientific Papers
Effect of tesamorelin on risk of development or progression of diabetic retinopathy and glycemic control in HIV-infected subjects with diabetes and central adiposity.
2020
Brown TT, Bedimo R, Goss OG, et al.
Oral presentation at: 22nd International Workshop on Co-morbidities and Adverse Drug Reactions in HIV; November 30-December 4 2020; virtual.
Clinical predictors of liver fibrosis presence and progression in HIV-associated NAFLD [abstract].
2020
Top Antivir Med.
Fourman LT, Stanley TL, Feldpausch M, et al.
28(1):128. Proceedings of the Conference on Retroviruses and Opportunistic Infections, 2020.
Clinical predictors of liver fibrosis presence and progression in HIV-associated NAFLD.
2020
Fourman LT, Stanley TL, Feldpausch M, et al.
Oral presentation #128 at: Conference on Retroviruses and Opportunistic Infections; March 8-11, 2020; Boston, Massachusetts, USA. Session O-10.
Clinical predictors of liver fibrosis presence and progression in HIV-associated NAFLD.
2020
Clin Infect Dis.
Fourman LT, Stanley TL, Zheng I, et al.
ciaa382.
Long-term efficacy, safety and durability of ibalizumab in expanded access study.
2019
HIV Medicine
Moyle G, Perno CF, Emu B, et al.
20 (suppl 9): 169. Proceedings of 17th (2019) European AIDS Conference